Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018924830> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2018924830 endingPage "1330" @default.
- W2018924830 startingPage "1329" @default.
- W2018924830 abstract "ThyroidVol. 23, No. 10 Letter to the EditorReduction in Thyroid Perfusion After Bevacizumab TreatmentAstrid A.M. van der Veldt, Adriaan A. Lammertsma, and Egbert F. SmitAstrid A.M. van der VeldtDepartment of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands.Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.Search for more papers by this author, Adriaan A. LammertsmaDepartment of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.Search for more papers by this author, and Egbert F. SmitDepartment of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.Search for more papers by this authorPublished Online:25 Sep 2013https://doi.org/10.1089/thy.2013.0147AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleReduction in Thyroid Perfusion After Bevacizumab Treatment. , 23(10), pp. 1329–1330FiguresReferencesRelatedDetailsCited byTyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disordersCritical Reviews in Oncology/Hematology, Vol. 141Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients Melissa G. Lechner, Chirag M. Vyas, Ole-Petter R. Hamnvik, Erik K. Alexander, P. Reed Larsen, Toni K. Choueiri, and Trevor E. Angell1 April 2018 | Thyroid, Vol. 28, No. 4VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis24 April 2017 | EMBO Molecular Medicine, Vol. 9, No. 6VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs22 July 2014 | Nature Reviews Endocrinology, Vol. 10, No. 9Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and TreatmentBioMed Research International, Vol. 2013 Volume 23Issue 10Oct 2013 InformationCopyright 2013, Mary Ann Liebert, Inc.To cite this article:Astrid A.M. van der Veldt, Adriaan A. Lammertsma, and Egbert F. Smit.Reduction in Thyroid Perfusion After Bevacizumab Treatment.Thyroid.Oct 2013.1329-1330.http://doi.org/10.1089/thy.2013.0147Published in Volume: 23 Issue 10: September 25, 2013Online Ahead of Print:July 25, 2013Online Ahead of Editing: April 2, 2013PDF download" @default.
- W2018924830 created "2016-06-24" @default.
- W2018924830 creator A5016904876 @default.
- W2018924830 creator A5021543324 @default.
- W2018924830 creator A5077018603 @default.
- W2018924830 date "2013-10-01" @default.
- W2018924830 modified "2023-10-12" @default.
- W2018924830 title "Reduction in Thyroid Perfusion After Bevacizumab Treatment" @default.
- W2018924830 cites W1539571840 @default.
- W2018924830 cites W1875554126 @default.
- W2018924830 cites W2000292756 @default.
- W2018924830 cites W2037383303 @default.
- W2018924830 cites W2038011542 @default.
- W2018924830 cites W2132272301 @default.
- W2018924830 cites W2144893998 @default.
- W2018924830 cites W2149456801 @default.
- W2018924830 cites W2162059553 @default.
- W2018924830 cites W2329503005 @default.
- W2018924830 doi "https://doi.org/10.1089/thy.2013.0147" @default.
- W2018924830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23548042" @default.
- W2018924830 hasPublicationYear "2013" @default.
- W2018924830 type Work @default.
- W2018924830 sameAs 2018924830 @default.
- W2018924830 citedByCount "6" @default.
- W2018924830 countsByYear W20189248302013 @default.
- W2018924830 countsByYear W20189248302014 @default.
- W2018924830 countsByYear W20189248302017 @default.
- W2018924830 countsByYear W20189248302018 @default.
- W2018924830 countsByYear W20189248302019 @default.
- W2018924830 crossrefType "journal-article" @default.
- W2018924830 hasAuthorship W2018924830A5016904876 @default.
- W2018924830 hasAuthorship W2018924830A5021543324 @default.
- W2018924830 hasAuthorship W2018924830A5077018603 @default.
- W2018924830 hasConcept C126322002 @default.
- W2018924830 hasConcept C143998085 @default.
- W2018924830 hasConcept C2776694085 @default.
- W2018924830 hasConcept C2777802072 @default.
- W2018924830 hasConcept C2779761222 @default.
- W2018924830 hasConcept C526584372 @default.
- W2018924830 hasConcept C71924100 @default.
- W2018924830 hasConceptScore W2018924830C126322002 @default.
- W2018924830 hasConceptScore W2018924830C143998085 @default.
- W2018924830 hasConceptScore W2018924830C2776694085 @default.
- W2018924830 hasConceptScore W2018924830C2777802072 @default.
- W2018924830 hasConceptScore W2018924830C2779761222 @default.
- W2018924830 hasConceptScore W2018924830C526584372 @default.
- W2018924830 hasConceptScore W2018924830C71924100 @default.
- W2018924830 hasIssue "10" @default.
- W2018924830 hasLocation W20189248301 @default.
- W2018924830 hasLocation W20189248302 @default.
- W2018924830 hasOpenAccess W2018924830 @default.
- W2018924830 hasPrimaryLocation W20189248301 @default.
- W2018924830 hasRelatedWork W2028827184 @default.
- W2018924830 hasRelatedWork W2037317309 @default.
- W2018924830 hasRelatedWork W2051540233 @default.
- W2018924830 hasRelatedWork W2090201823 @default.
- W2018924830 hasRelatedWork W2091442233 @default.
- W2018924830 hasRelatedWork W2146312028 @default.
- W2018924830 hasRelatedWork W2733092439 @default.
- W2018924830 hasRelatedWork W2748952813 @default.
- W2018924830 hasRelatedWork W3142026086 @default.
- W2018924830 hasRelatedWork W3146277049 @default.
- W2018924830 hasVolume "23" @default.
- W2018924830 isParatext "false" @default.
- W2018924830 isRetracted "false" @default.
- W2018924830 magId "2018924830" @default.
- W2018924830 workType "article" @default.